Meeting News
March 3, 2017
SEATTLE — Researchers at the Conference on Retroviruses and Opportunistic Infections presented 24-week data of a phase 3 trial that showed…
Meeting News
March 1, 2017
The results of two trials, which examined the use of nanotechnology to improve drug therapies for HIV patients, found that a new nanomedicine method…
Meeting NewsPerspective
February 27, 2017
Oral pre-exposure prophylaxis, or PrEP, for HIV prevention has a similar efficacy in women with “abnormal” vs. “normal”…
February 24, 2017
As a service to its readers, Healio Internal Medicine presents the top five news articles from the 2017 Conference on Retroviruses and Opportunistic…
Meeting NewsPerspective
February 23, 2017
SEATTLE — Several studies presented at CROI 2017 explored the link between substance abuse and HIV, with researchers noting opportunities to…
Meeting News
February 22, 2017
Merck recently announced the results of a phase 3 clinical trial that found doravirine, an investigational non-nucleoside reverse transcriptase…
Meeting News
February 21, 2017
SEATTLE —Despite a high level of interest in pre-exposure prophylaxis, or PrEP, among young black men who have sex with men, researchers…
Meeting News
February 20, 2017
SEATTLE — Just 1 year after quitting smoking, people with HIV face roughly the same risk of acquiring most cancers as those with the virus who…
Meeting News
February 20, 2017
SEATTLE — Incidence rates of acute hepatitis C virus are expected to decrease substantially over the coming years in the Netherlands, according…
Meeting News
February 20, 2017
SEATTLE — Integration of ART into maternal and child health services during the postnatal period leads to significant improvements in…